Scar Treatment Market Size, Share & Trends Analysis Report By Scar Type (Atrophic, Hypertrophic & Keloid Scars, Stretch Marks), By Product (Injectables, Topical, Laser), By End Use, And Segment Forecasts, 2019 - 2026

Report Overview

The global scar treatment market size was valued at USD 17.94 billion in 2018 and is expected to witness a CAGR of 9.9% over the forecast period. Growing concern among people regarding their aesthetic appearance is one of the major factors driving the demand for scar treatment products. Severe scars or marks caused due to road accidents is also a key factor contributing to the market growth.

The data published by WHO quotes that due to road accidents nearly 10 Million people are injured every year. Topical products generally help in reducing such marks. Road accidents also lead to high demand for cosmetic surgeries, which further boosts the demand for laser instruments. Rising cases of burn injuries is another factor supporting the scar removal treatment market growth.

The global market is experiencing immense technological developments with introduction of laser therapy. For instance, MedLite C6, a Q-switched laser-based instrument developed for the treatment of acne. Laser instruments help in destroying scar tissue. Treatment with laser products involves both surgical and nonsurgical procedures. Plastic and reconstructive surgeries are also a part of surgical laser treatment process.

Thus, laser products are anticipated to witness the fastest CAGR over the forecast period. North America led the global industry in 2018 and is projected to retain its leading position throughout the forecast years owing to high penetration of laser-based products in skin rejuvenation and scar treatment. Some of the prominent companies in the scar removal treatment market include Merz, Inc.; Smith & Nephew plc; Lumenis; Sonoma Pharmaceuticals, Inc.; Scarheal, Inc.; Enaltus LLC; Mölnlycke Health Care; CCA Industries, Inc.; and Cynosure, Inc.

Product Insights

Topical products was the largest segment in 2018 and is projected to maintain its dominance in future. This is because topical gels, creams, and silicone sheets are commonly available as Over-the-Counter (OTC) products, which enhances their usability as a treatment for scars. Laser products are anticipated to witness the highest growth owing to high demand for laser surgeries for the treatment of acne, keloid, or stretch marks as these procedures cause minimal discomfort.

Scar Type Insights

Amongst the types of scars, atrophic held the largest share in 2018 as these scars are generally treated with topical creams and gels that are easily available OTC. The treatment used for these scars helps stimulate the skin’s natural healing process to replace collagen, elastin, and other fibrous tissues. Contracture scars often occur after a second or third degree burn when the burn scar matures, thickens, and tightens. In most cases, contracture scars are treated with topical products.

Laser treatments are also used in such cases, aiding in loosening of the skin surrounding the wound. Use of silicone sheets allows the moisture to retain, while preventing any additional scar tissue formation. Hypertrophic and keloid segment also generated significant revenue in 2018. Topical creams, silicone gels, and silicone gel sheets are very effective for the treatment of keloids.

End-Use Insights

On the basis of end-use, the scar treatment market has been segmented into hospitals, clinics, retail pharmacies, and e-commerce (online retailing). Hospital segment held the largest share in 2018 owing to the fact that products such as topical creams and gels, laser instruments, and steroid injections are widely used for scar removal in hospital settings.

Increasing number of clinics that offer precise and latest technological procedures in the field of dermatology will drive the clinics segment. Retail pharmacies/e-commerce segment is expected to witness the fastest CAGR over the forecast period as online websites offer a wide range of products from topical creams and gels, portable laser instruments, to steroid injections. Moreover, people often tend to buy products online due to discounted prices and several other offers.

Regional Insights

In 2018, North America dominated the market owing to quick adoption of advanced products. Furthermore, high awareness levels regarding aesthetic appeal is contributing to the market growth. U.K. is a major contributor to the European market. According to the British Association of Plastic, Reconstructive and Aesthetic Surgeons (BAPRAS), the demand for aesthetic plastic surgeries and scar treatment is increasing as a result of rising number of NHS plastic surgery units and centers in the U.K. Moreover, plastic surgery for reconstructive purpose is free under the National Health Services (NHS). Asia Pacific is projected to exhibit the highest CAGR over the forecast period.

Scar Treatment Market Share Insights

Some of the key companies in the scar removal treatment market are Smith & Nephew plc; Merz, Inc.; Lumenis; Enaltus LLC; Sonoma Pharmaceuticals, Inc.; Mölnlycke Health Care; Cynosure, Inc.; CCA Industries, Inc.; Scarheal, Inc., NewMedical Technology, Inc.; and Suneva Medical, Inc. Most of these companies have undertaken strategies, such as product launch, mergers & acquisitions, and geographical expansions to cater to the unmet demands. For instance, in 2013, Enaltus LLC acquired the assets of ScarAway brand to expand its portfolio of scar treatment products. In 2015, Lumenis acquired Pollogen Ltd., an Israel-based medical aesthetic company, with an aim to expand its aesthetic products portfolio. In 2016, Cynosure received U.S. FDA clearance for PicoSure, a laser delivery system.

Scar Treatment Market Report Scope

Segments Covered in the Report

This report forecasts revenue and volume growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global scar treatment market report on the basis of product, scar type, end-use, and region:

• Product Outlook (Revenue, USD Million, 2015 - 2026)

  • Topical Products

    • Creams

    • Gels

    • Silicon Sheets

    • Others

  • Laser Products

    • CO2 Laser

    • Pulse-dyed Laser

    • Others

  • Injectables

  • Others

• Scar Type Outlook (Revenue, USD Million, 2015 - 2026)

  • Atrophic

  • Hypertrophic and Keloid

  • Contracture

  • Stretch Marks

• End-Use Outlook (Revenue, USD Million, 2015 - 2026)

  • Hospitals

  • Clinics

  • Retail Pharmacies/E-commerce

• Regional Outlook (Revenue, USD Million, 2015 - 2026)

  • North America

    • The U.S.

    • Canada

  • Europe

    • Germany

    • The U.K.

    • Spain

    • France

    • Italy

    • Russia

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Asia Pacific

    • Japan

    • China

    • India

    • South Korea

    • Singapore

    • Australia

  • MEA

    • South Africa

    • Saudi Arabia

    • UAE